MedCity News April 26, 2024
Peter Bannister and Alan Thomas Kohler

This rapidly growing field marries bioinformatics and pharmacology and represents a transformative new era of precision medicine and highly personalized treatments.

Pharmacogenomics (PGx), the study of how genetic profiles impact an individual’s responses to medication, has already begun to help healthcare providers (HCPs) optimize care through its capacity to preemptively enhance drug efficacy, minimize adverse side effects, and improve patient experiences. This rapidly growing field marries bioinformatics and pharmacology and represents a transformative new era of precision medicine and highly personalized treatments, one that serves patients by supporting clinicians to better predict therapeutic responses and more accurately optimize drug dosages.

But, with data-driven solutions come data-driven challenges, not the least of which is the size and complexity of the datasets...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Pharma / Biotech, Precision Medicine, Primary care, Provider, Technology
Retail giants can’t figure out health care
How Mass General Brigham provides emergency care at home
Bridging care and culture: a Filipino doctor’s journey in direct primary care
75% of Americans think mental health issues are treated worse than physical illness, new survey says. Here’s why
Patience and purpose: essential lessons on transformation [PODCAST]

Share This Article